Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Concordia Healthcare Corp. T.CXR.R



TSX:CXR.R - Post by User

Comment by marxathon Sep 29, 2016 8:32pm
132 Views
Post# 25293061

RE:RE:RE:RE:Shorts Have 5 Trading Sessions to Cover

RE:RE:RE:RE:Shorts Have 5 Trading Sessions to Cover
Lumberfeverlong wrote: That is a post from last quarter being recycled by the short and distort gang. Rest assured, I'll be doing the same when this thing turns around.  
Register123 wrote:


At this point, I think longs have two alternatives to hope for:

1) There may be a company willing to buy out CXR shareholders, but at a price that is not much more than it is currently trading for (I think those who are hoping for a $15+ takeover price are dreaming, but hey, anything's possible.........)

2) If CXR sells off some assets to pay down their high-interest debt, they could probably survive for a number of years, but I wouldn't count on much of an increase in share price.....CXR could hover in the $3 to $6 price range for the rest of its existence..........

How's that for optimism!!!




If there has been any distortion of fundamentals on the part of the shorts it has been minimal, and far less destructive than the pump a defunct mission undertaken by banks, institutions, assorted analysts and half wit retail like yourself since November of last year.

The AMco purchase was a death sentence from the get go. Brexit, unexpected  generic competition ( lmao!) and the NHS investigation has only accelerated the process.

Remember, remaining solvent a good investment not make.







<< Previous
Bullboard Posts
Next >>